(1R,2R)-1-Amino-1-(5-bromopyridin-3-yl)propan-2-ol

(1R,2R)-1-Amino-1-[2-(trifluoromethoxy)phenyl]propan-2-OL

(1R,2R)-1-Amino-1-(4-chloro-2-methoxyphenyl)propan-2-OL

(1R,2R)-1-Amino-1-[3,5-bis(trifluoromethyl)phenyl]propan-2-OL

(1R,2R)-1-Amino-1-(5-chloro-2-methoxyphenyl)propan-2-OL

(1R,2R)-1-Amino-1-[2-(trifluoromethyl)phenyl]propan-2-OL

(1R,2R)-1-Amino-1-(4-methylpyridin-3-yl)propan-2-ol

(1R,2R)-1-Amino-1-(2-methylthiophenyl)propan-2-OL

(1R,2S,7S,8R,9R)-2,6,6,9-tetramethyltricyclo[5.4.0.02,9]undecan-8-ol

Chloro(2-methylpropyl)silane

1-Bromo-2-methoxy-3,3-dimethylbutane

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-trans)-

Tert-butyl 2-(butylamino)benzoate

Vilanterol metabolite M30

2-hydroxy-5-(4-hydroxyphenyl)-1H-phenalen-1-one

1,2-Anthracenediol, 1,2,3,4-tetrahydro-, cis-

N-Methylschinifoline

[R,(+)]-beta-Methylcyclohexane-1-butanol